The butyl homologue of Δ9-THC, Δ9-THCB, has been shown to have an affinity for the human CB1 and CB2 receptors comparable to that of (-)-trans-Δ9-THC. THCb's has demonstrated possible analgesic and anti-inflammatory properties yet is still being further researched.